Inter-Ed Faculty Of Clinical Research India (Ifcr) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 18 Year, 8 Months
- Last Filing with ROC 31 Mar 2008
- Open Charges ₹ 0.77 M
About Inter-Ed Faculty Of Clinical Research India (Ifcr)
Inter-Ed Faculty Of Clinical Research India (Ifcr) Private Limited (IFOCRIIPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 May 2006 and has a history of 18 years and eight months. Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2008. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.77 M.
Sunil Joseph, Anitha Kunnumpuram, and Anil Joseph serve as directors at the Company.
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U73100KL2006PTC019451
- Company No.
019451
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 May 2006
- Date of AGM
30 Sep 2008
- Date of Balance Sheet
31 Mar 2008
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Inter-Ed Faculty Of Clinical Research India (Ifcr)?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sunil Joseph | Director | 23-May-2006 | Current |
Anitha Kunnumpuram | Director | 23-May-2006 | Current |
Anil Joseph | Director | 23-May-2006 | Current |
Financial Performance of Inter-Ed Faculty Of Clinical Research India (Ifcr).
Enhance accessibility to Inter-Ed Faculty Of Clinical Research India (Ifcr)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Inter-Ed Faculty Of Clinical Research India (Ifcr)?
Unlock access to Inter-Ed Faculty Of Clinical Research India (Ifcr)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.77 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.08 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
12 Oct 2007 | Bank Of India | ₹0.77 M | Open |
How Many Employees Work at Inter-Ed Faculty Of Clinical Research India (Ifcr)?
Unlock and access historical data on people associated with Inter-Ed Faculty Of Clinical Research India (Ifcr), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inter-Ed Faculty Of Clinical Research India (Ifcr), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inter-Ed Faculty Of Clinical Research India (Ifcr)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.